Table 1. Correlation between HOXA6 protein expression and the clinicopathological parameters of gastric carcinoma.
| Features | Total number (n =85) | HOXA6 expression | P | |
| Low | High | |||
| Age (years) | 0.062 | |||
| <60 | 33 | 8(24.2%) | 25(75.8%) | |
| ≥60 | 52 | 23(44.2%) | 29(55.8%) | |
| Gender | 0.347 | |||
| Male | 52 | 21(40.4%) | 31(59.6%) | |
| Female | 33 | 10(30.3%) | 23(69.7%) | |
| Differentiation | 0.002 | |||
| Well | 21 | 14(66.7%) | 7(33.3%) | |
| Moderate | 26 | 9(34.6%) | 17(65.4%) | |
| Poor | 38 | 8(21.1%) | 30(78.9%) | |
| Lymph node metastasis | <0.001 | |||
| Yes | 63 | 15(23.8%) | 48(76.2%) | |
| No | 22 | 16(72.7%) | 6(27.3%) | |
| Tumor size (cm3) | <0.001 | |||
| <5 | 15 | 10(66.7%) | 5(33.3%) | |
| ≥5 | 70 | 21(30.0%) | 49(70.0%) | |
| AJCC T stage | <0.001 | |||
| T1, T2 | 13 | 12(92.3%) | 1(7.7%) | |
| T3, T4 | 72 | 19(36.5%) | 53(63.5%) | |
| AJCC TNM stage | <0.001 | |||
| I, II | 35 | 21(60.0%) | 14(40.0%) | |
| III, IV | 50 | 10(20.0%) | 40(80.0%) | |